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Volume 57, Number 5S Abstracts 23SResults: There were 390 patients (75%) with JRA/
PRAs considered potential candidates for the two devices.
Proximal seal (>15 mm) could be achieved in all patients
using p-Branch and in 61% of the patients using Ven-
tana stent-graft (P < .0001). The ability to incorporate
visceral arteries (Fig) was greater using Ventana (90%)
compared to p-Branch (61%; P < .0001) design. Less
than a third of patients met strict IFU criteria for using
Ventana (25%) or p-Branch (32%; P < .05) devices.
Using liberal IFU criteria, 42% of patients were candidates
for Ventana and 49% for p-Branch (P < .03). Overall
63% of the patients with JRA/PRAs were candidates for
endovascular repair using one of the two devices.
Conclusions: p-Branch design has greater anatom-
ical feasibility and achieves proximal seal in all patients
with JRA/PRAs, but is not able to incorporate visceral
arteries in 40% of patients. Ventana design allows incor-
poration of the visceral arteries in 90% of patients, but fails
to provide sufﬁcient seal in 40%. Nearly 40% of JRA/PRAs
do not meet anatomical criteria for endovascular repair
using one the two devices, justifying need for additional
designs.
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Smooth Muscle Cells from Abdominal Aortic
Aneurysms Are Unique and Can Independently and
Synergistically Degrade Insoluble Elastin
Nathan D. Airhart, Bernard Brownstein, William
Schierding, Perren Cobb, Batool Arif, Terri Ennis,
Robert Thompson, John A. Curci. Surgery, Washington
University School of Medicine, St Louis, Mo
Objectives: The purpose of this study was to further
elucidate the role of the vascular smooth muscle cell
(SMC) in abdominal aortic aneurysm (AAA) disease. Our
hypothesis is that AAA-SMC are unique and actively partic-
ipate in the process of degrading the aortic matrix.
Methods: Using microarray, we compared whole-
genome expression proﬁles of SMC from AAA, normal
abdominal aorta (NAA) and carotid endarterectomy
(CEA). We quantiﬁed elastolytic activity by culturing
SMC in [3H] elastin-coated plates and measuring solubi-
lized tritium in the media after 7 days. MMP-2 and
MMP-9 production was assessed using real-time PCR,
zymography and western blotting.
Results: Uniquegene expressionpatternswereobserved
for each SMC type. Under basal conditions, AAA-SMC had
much greater elastolytic activity than NAA (+68%; P <
.001) and CEA-SMC (+45%; P < .001). Zymographyshowed a relative increase of active-MMP-2 (62kD) in media
from AAA-SMC. AAA-SMC demonstrated 2 fold greater
expression of MMP-2 mRNA (P < .05) and 7.3 fold greater
MMP-9 expression (P< .01) than NAA-SMC. Culture with
activatedU937monocytes led to a synergistic increase in elas-
tolytic activity by AAA-SMC (41%; P< .001). This effect was
not apparent in NAA or CEA co-cultures (P ¼ .99). Co-
culture with U937 led to a large increase in MMP-9 mRNA
in both AAA and NAA-SMC (P < .001). MMP-2 mRNA
expression was not affected. Western blots of conditioned
media showed increased MMP-9 (92 kD) protein secretion
by AAA-SMC/U937 cultures which was approximately 4-
fold greater than NAA-SMC/U937 (P < .001). AAA-
SMC/U937 co-cultures also exhibited a large increase in
active-MMP2 (62 kD) in conditionedmedia, an effect which
was much less apparent in NAA/U937 media (P < .01).
Conclusions: AAA-SMC exhibit a unique gene
expression pattern and have a pro-elastolytic phenotype
that is augmented by macrophages. This may occur via
a failure of post-transcriptional control of MMP-9 protein
synthesis, leading to increased production and activation
of elastolytic MMPs.
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Five Years Results of Aortic Arch Debranching
Paola De Rango2, Ciro Ferrer1, Carlo Coscarella1, Gioele
Simonte2, Enrico Cieri2, Luca Farchioni2, Fabio Verzini2,
Gianbattista Parlani2, Piergiorgio Cao1. 1Vascular
Surgery, Hospital S Camillo Forlanini, Rome, Italy;
2Vascular and Endovascular Surgery; University of
Perugia, Hospital S.M.Misericordia, Perugia, Italy
Objectives: To evaluate early and ﬁve years results of
partial or total arch debranching.
Methods: In 2001-2012, 100 consecutive patients
underwent elective hybrid arch repair with debranching
and stentgraft (TEVAR). Outcomes were stratiﬁed for
extension of arch involvement. Primary outcomes were
perioperative (30-day) and ﬁve years mortality.
Results: Mean patients age was 70.1years and 88 were
males. 16 archeswere repaired for dissection.Twenty patients
required total debranching for diseases extended to Zone-0.
In 55, debranching and TEVAR procedures were staged.
At 30-day, death, stroke and paraplegia occurred in 6, 4
and 3 patients respectively. In 80, requiring partial debranch-
ing, the same outcome rates were 2.5%, 3.8% and 2.5%,
respectively. In patients with dissections, there was no death,
paraplegia or stroke. Extension to ascending aorta requiring
total arch debranching was the only multivariate indepen-
dent predictor for mortality (odds ratio, 11.4; 95% Conﬁ-
dence Interval 1.91-68.4; P ¼ .008), but not for stroke
or paraplegia. One retrograde dissection with successful
repair, occurred after total debranching. Kaplan-Meier
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and 69.7%. Two reinterventions for endoleak were required
and no migration or late aneurysm related mortality was
recorded.
Conclusions: The incidence of stroke is acceptable
after both total and partial arch debranching. Total
debranching is an important predictor for mortality. Retro-
grade dissection may be infrequent complication with care-
ful arch approach. After the perioperative interval,
debranching is a safe and durable procedure up to 5 years.
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Eligiblity for Endovascular Repair of Short Neck
Abdominal Aortic Aneurysms
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Objectives: Using the CHAP database of nearly
10,000 patients nationwide, we examined eligibility for
EVAR in patients with a short neck AAA (snAAA), where
the neck length < 10 mm, and identiﬁed the anatomic
parameters driving endograft (EVG) ineligibility.
Methods: Preoperative CT scans from eleven US clin-
ical sites were prospectively entered into a database from
7/96 to 11/12. A blinded third-party, M2S, recorded
standardized measurements from the 3D reconstructions.
Two currently marketed EVG in the US are labeled to treat
snAAA, with neck angulation #45 deg and neck lengthsTable. Eligibility for two marketed EVGs excluding iliac and
anatomic parameters
snAAA < 5 cm snAAA $ 5 c
M (512) W (324) M (1733) W
Cook fenestrated, % 44 44 42
Trivascular ovation, % 24 10 16
Neck length, mm 6 (3-9) 5 (2-9) 6 (2-9) 5
Neck angulation, deg 31 (16-55) 38 (18-63) 37 (18-61) 48
Neck diameter, mm 24 (26-35) 23 (18-34) 25 (20-97) 24$4 mm (Cook Fenestrated) and >7 mm (Trivascular
Ovation). The EVAR criteria were analyzed in 2245 men
(M) and 1079 women (W) with snAAA.
Results: Of the 9848 AAAs, 3324 have snAAA (34%).
Even if iliac and access criteria are excluded, EVAR eligi-
bility for snAAA is at most 45%. In snAAA >5 cm diam-
eter, neck angulation is 48 deg for women and 37 deg
for men (P < .01). Women are more likely to have neck
length < 4 mm and neck angulation > 45 deg (risk ratio
is 90). Only 6% of patients are eligible for both EVG.
Larger AAAs are not less likely to be eligible for fenestrated
EVAR (Table; P ¼ NS).
Conclusions: One-third of AAAs have a short neck,
and less than half of these are eligible for current EVG,
even with a fenestrated option. Neck angulation and length
continue to challenge EVAR eligibility, especially for
women. Eligibility for EVAR does not lessen as aneurysms
enlarge, so there is no indication for early repair.
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Video Presentation
Percutaneous Endovascular Repair of Aortoiliac
Aneurysm Using Iliac Branch Device
Mateus P. Correa, Gustavo S. Oderich. Division of Vascular
and Endovascular Surgery, Mayo Clinic, Rochester, Minn
Background: Exclusion of one or both internal iliac
arteries (IIA) during endovascular aortic aneurysm repair
(EVAR) has been associated with a predictable rate of
pelvic ischemic complications. We present the preoperative
planning and technique of implantation of Iliac Branch
Device (IBD, Cook Inc., Brisbane, Australia) in a patient
with bilateral common iliac artery (CIA) aneurysms using
total percutaneous approach.
Technical Description: Computed tomography angi-
ography (CTA) was used to determine measurementsaccess criteria; median (10th-90th percentile) values of
m snAAA > 5.5 cm snAAA > 6.5 cm
(755) M (1152) W (437) M (465) W (154)
45 45 45 45 43
7 14 6 18 3
(2-9) 6 (2 9) 5 (2-9) 5 (2 9) 4 (1-8)
(25-74) 39 (19 64) 51 (28-77) 43 (20 67) 57 (32-81)
(19-37) 25 (21 38) 24 (19-39) 26 (21 41) 24 (19-42)
